Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Diffuse Intrinsic Pontine Gliomas (DIPG): early-phase trial registry
1 of 2 indexed Diffuse Intrinsic Pontine Gliomas (DIPG) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Diffuse Intrinsic Pontine Gliomas (DIPG): 2 US clinical trials tracked, 1 recruiting.
Diffuse Intrinsic Pontine Gliomas (DIPG) is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Pediatric Brain Tumor Consortium, running 1 of these trials.
Enrollment posture brief
Registry condition diffuse-intrinsic-pontine-gliomas-dipg
OPEN 1 | RECR 50% | LATE 0 | EARLY 2 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Diffuse Intrinsic Pontine Gliomas (DIPG) lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Diffuse Intrinsic Pontine Gliomas (DIPG) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Diffuse Intrinsic Pontine Gliomas (DIPG) is recruiting above its size-band peers.
1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Nationwide Children's Hospital
NCT06838676
Phase I Study of APX005M in Pediatric Central Nervous System Tumors
Pediatric Brain Tumor Consortium
NCT03389802
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Diffuse Intrinsic Pontine Gliomas (DIPG) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Diffuse Intrinsic Pontine Gliomas (DIPG) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Diffuse Intrinsic Pontine Gliomas (DIPG) page
2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Diffuse Intrinsic Pontine Gliomas (DIPG) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Pediatric Brain Tumor Consortium sponsors the most Diffuse Intrinsic Pontine Gliomas (DIPG) trials on record, review their full trial history before evaluating a specific study. See Pediatric Brain Tumor Consortium's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diffuse Intrinsic Pontine Gliomas (DIPG) condition card totals 2 registered trials; most-linked intervention APX005M treatment for newly diagnosed DIPG patients; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.